Yıl: 2021 Cilt: 54 Sayı: 2 Sayfa Aralığı: 166 - 174 Metin Dili: İngilizce DOI: 10.5505/aot.2021.23540 İndeks Tarihi: 20-12-2021

Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer

Öz:
Aim: Colon cancer is one of the most common types of malignant tumours in the world. Colon cancer ranks fourth among cancer-related deaths. Lymphovascular invasion (LVI) is the tumour involvement of small lymphatic or blood (typically venous) vessels while perineural invasion (PNI) is the growth of the tumour in, around, and along the nerves and nerve sheaths. In our study, we investigated the effects of LVI and PNI on prognosis, tumour stages, and lymph node metastasis in colon cancer patients. Methods; The data of patients, who underwent colon cancer surgery in our clinic in the period between February 2013 and January 2020, were analyzed retrospectively. The surgery and pathology reports, demographic characteristics, and overall survival of the patients were examined. Results: A total of 248 patients were operated due to colon cancer. LVI and PNI were present in 120 (48.3%) and 105 (41.9%) patients, respectively. The relationship of the grade, of the presence of positive lymph nodes, LVI, and PNI, and of the T- and N-stages with the survival were statistically significant with the following p-values of 0.028, <0.001, <0.001, <0.001, 0.005, and <0.001, respectively. When the relationship of LVI and PNI with other factors was examined, it was shown that there was a statistically significant relationship in both groups in terms of T and N stage, metastatic lymph node and survival time. (p <0.001) Conclusion: Because the presence of LVI and PNI is a determinant of prognosis and lymph node metastasis especially in early-stage patients; we think that close follow-up of patients with LVI and PNI and the evaluation of such patients by a multidisciplinary council for the administration of adjuvant therapy, may affect prognosis favourably.
Anahtar Kelime:

Kolon Kanserinde Lenfovasküler ve Perinöral İnvazyonun Prognostik Önemi

Öz:
Amaç: Kolon kanseri tüm dünyada en sık görülen maligniteler arasındadır. Kansere bağlı ölüm nedenleri arasında 4. sıradadır. Lenfovasküler invazyon (LVI), küçük lenfatik veya kan (tipik olarak venöz) damarların tümör tarafından tutulması iken perinöral invazyon (PNI) ise sinirlerin ve sinir kılıflarının içinde, çevresinde ve boyunca tümörün büyümesidir. Çalışmamızda LVI ve PNI’nın kolon kanserli hastalarda prognoz, tümör evresi ve lenf nodu metastazına etkisi araştırdık. Yöntem: Şubat 2013-Ocak 2020 tarihleri arasında kliniğimizde kolon kanseri nedeniyle opere edilen hastaların verileri retrospektif olarak inceledi. Hastaların ameliyat ve patoloji raporları, demografik özellikleri, genel sağkalımları incelendi. Bulgular: 248 hasta kolon kanseri nedeniyle opere edildi. 120 hastada LVI, 105 (41.9%) PNI hastada vardı. Grade, lenf nodu pozitifliği, LVI, PNI, T ve N evrelerinin sağkalımla ilişkisi istatistiksel olarak anlamlı bulunmuş olup sırasıyla p değerleri: 0.028, <0.001, <0.001, <0.001, 0.005 ve <0.001’dir. LVI ve PNI'nin diğer faktörlerle ilişkisi incelendiğinde, T ve N evresi, metastatik lenf nodu ve sağkalım süresi açısından her iki grupta da istatistiksel olarak anlamlı bir ilişki olduğu gösterilmiştir. (p <0,001) Sonuç: LVI ve PNI varlığı özellikle erken evre hastalarda prognozun, lenf nodu metastazının bir belirleyici olmasından dolayı; LVI ve PNI pozitif olan hastaların yakın izlemin, adjuvan tedavi için multidisipliner konseyde değerlendirilmenin prognoza olumlu etkilerinin olabileceğini düşünmekteyiz.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐ Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015; 65(2): 87- 108.
  • 2. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier A. Time trends in the treatment and survival of recurrences from colorectal cancer. Annals of oncology. 2005; 16(5): 756-61.
  • 3. Zlobec I, Lugli A. Prognostic and predictive factors in colorectal cancer. Postgraduate medical journal. 2008; 84(994): 403-11.
  • 4. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, et al. Colorectal cancer statistics, 2017. CA: a cancer journal for clinicians. 2017; 67(3): 177-93.
  • 5. Shah MA, Renfro LA, Allegra CJ, André T, De Gramont A, Schmoll H-J, et al. Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database. Journal of Clinical Oncology. 2016; 34(8): 843.
  • 6. Nikberg M, Chabok A, Letocha H, Kindler C, Glimelius B, Smedh K. Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica. 2016; 55(12): 1418-24.
  • 7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in Colon Cancer (Version 1.2017). 2017.
  • 8. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Archives of pathology & laboratory medicine. 2000; 124(7):979-94.
  • 9. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. Journal of clinical oncology. 2009; 27(31): 5131.
  • 10. Quah H-M, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, et al. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Diseases of the colon & rectum. 2008; 51(5): 503-7.
  • 11. Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz A, Greene F. AJCC cancer staging manual: Springer New York; 2010.
  • 12. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. The American journal of surgical pathology. 2008; 32(12): 1816.
  • 13. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period. Annals of surgery. 2008; 248(6): 968-78.
  • 14. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer. The American journal of surgical pathology. 2016; 40(1): 103-12.
  • 15. Minsky BD, Mies C, Rich TA, Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. International Journal of Radiation Oncology* Biology* Physics. 1989; 17(2): 311-8.
  • 16. Batsakis J. Nerves and neurotropic carcinomas. The Annals of otology, rhinology, and laryngology. 1985; 94(4 Pt 1):426.
  • 17. Compton C, Fenoglio‐Preiser CM, Pettigrew N, Fielding LP. American joint committee on cancer prognostic factors consensus conference: colorectal working group. cancer. 2000; 88(7): 1739-57.
  • 18. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer. 1988;61(7):1417- 24.
  • 19. Artac M, Turhal NS, Kocer M, Karabulut B, Bozcuk H, Yalcin S, et al. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. Tumori Journal. 2014;100(2):143-8.
  • 20. Sun Q, Liu T, Liu P, Luo J, Zhang N, Lu K, et al. Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery. Journal of cancer. 2019;10(10):2243.
  • 21. Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. International Journal of Surgery. 2017;37:42-9.
  • 22. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012; 118(3): 628-38.
  • 23. Poeschl EM, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, et al. Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. Journal of Clinical Oncology. 2010; 28(21): e358-e60.
  • 24. Huh JW, Kim HR, Kim YJ. Prognostic value of perineural invasion in patients with stage II colorectal cancer. Annals of surgical oncology. 2010; 17(8): 2066-72.
  • 25. Jin M, Frankel WL. Lymph node metastasis in colorectal cancer. Surgical Oncology Clinics. 2018; 27(2): 401-12.
  • 26. Rasheed S, Bowley D, Aziz O, Tekkis P, Sadat A, Guenther T, et al. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Disease. 2008; 10(3):231-8.
  • 27. Bayar S, Saxena R, Emir B, Salem R. Venous invasion may predict lymph node metastasis in early rectal cancer. European Journal of Surgical Oncology (EJSO). 2002; 28(4): 413-7.
  • 28. Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Journal of clinical oncology. 2004; 22(10): 1797-806.
  • 29. Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. Journal of clinical oncology. 2002; 20(19): 3999- 4005.
  • 30. Yun HR, Kim HC, Yun SH, Lee WY. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer. Hepato-gastroenterology. 2012; 59(120): 2466- 71.
  • 31. Casadaban L, Rauscher G, Aklilu M, Villenes D, Freels S, Maker AV. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer. 2016; 122(21): 3277-87.
  • 32. Lim S-B, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Diseases of the colon & rectum. 2010; 53(4): 377-84.
  • 33. McLeod H, Murray G. Tumour markers of prognosis in colorectal cancer. British journal of cancer. 1999; 79(2): 191-203.
  • 34. Huh JW, Kim HR, Lee JH, Kim YJ. Comparison of cyclooxygenase-2 and CD44 mRNA expression in colorectal cancer and its relevance for prognosis. Virchows Archiv. 2009; 454(4): 381- 7.
  • 35. Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: A national cancer institute–national surgical adjuvant breast and bowel project collaborative study. Journal of Clinical Oncology. 2003; 21(2): 241-50.
  • 36. Watanabe T, Wu T-T, Catalano PJ, Ueki T, Satriano R, Haller DG, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. New England Journal of Medicine. 2001; 344(16): 1196-206.
  • 37. Li K, Luo H, Huang L, Luo H, Zhu X. Microsatellite instability: a review of what the oncologist should know. Cancer cell international. 2020; 20(1): 1-13.
APA Yüksel C, Culcu S, Gojayev A, Demirci S, Ünal A (2021). Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. , 166 - 174. 10.5505/aot.2021.23540
Chicago Yüksel Cemil,Culcu Serdar,Gojayev Afig,Demirci Salim,Ünal Ali Ekrem Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. (2021): 166 - 174. 10.5505/aot.2021.23540
MLA Yüksel Cemil,Culcu Serdar,Gojayev Afig,Demirci Salim,Ünal Ali Ekrem Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. , 2021, ss.166 - 174. 10.5505/aot.2021.23540
AMA Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. . 2021; 166 - 174. 10.5505/aot.2021.23540
Vancouver Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. . 2021; 166 - 174. 10.5505/aot.2021.23540
IEEE Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A "Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer." , ss.166 - 174, 2021. 10.5505/aot.2021.23540
ISNAD Yüksel, Cemil vd. "Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer". (2021), 166-174. https://doi.org/10.5505/aot.2021.23540
APA Yüksel C, Culcu S, Gojayev A, Demirci S, Ünal A (2021). Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. ACTA ONCOLOGICA TURCICA, 54(2), 166 - 174. 10.5505/aot.2021.23540
Chicago Yüksel Cemil,Culcu Serdar,Gojayev Afig,Demirci Salim,Ünal Ali Ekrem Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. ACTA ONCOLOGICA TURCICA 54, no.2 (2021): 166 - 174. 10.5505/aot.2021.23540
MLA Yüksel Cemil,Culcu Serdar,Gojayev Afig,Demirci Salim,Ünal Ali Ekrem Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. ACTA ONCOLOGICA TURCICA, vol.54, no.2, 2021, ss.166 - 174. 10.5505/aot.2021.23540
AMA Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. ACTA ONCOLOGICA TURCICA. 2021; 54(2): 166 - 174. 10.5505/aot.2021.23540
Vancouver Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer. ACTA ONCOLOGICA TURCICA. 2021; 54(2): 166 - 174. 10.5505/aot.2021.23540
IEEE Yüksel C,Culcu S,Gojayev A,Demirci S,Ünal A "Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer." ACTA ONCOLOGICA TURCICA, 54, ss.166 - 174, 2021. 10.5505/aot.2021.23540
ISNAD Yüksel, Cemil vd. "Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer". ACTA ONCOLOGICA TURCICA 54/2 (2021), 166-174. https://doi.org/10.5505/aot.2021.23540